Does anti-RANKL therapy prevent glucocorticoid induced bone loss and promote muscle function in a mouse model of Duchenne muscular dystrophy

Project Details

StatusFinished
Effective start/end date1/07/21 → 30/06/22

Funding

  • Lifearc: £99,444.79